These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2909691)

  • 1. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas.
    Saito T; Tanaka R; Kouno M; Washiyama K; Abe S; Kumanishi T
    J Neurosurg; 1989 Jan; 70(1):81-5. PubMed ID: 2909691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.
    Miescher S; Whiteside TL; de Tribolet N; von Fliedner V
    J Neurosurg; 1988 Mar; 68(3):438-48. PubMed ID: 3257792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
    List AF; Spier CM; Miller TP; Grogan TM
    Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
    Saito T; Tanaka R; Takai N; Hara N; Yoshida S
    No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas.
    Vaquero J; Coca S; Magallón R; Pontón P; Martinez R
    J Neurosurg; 1990 Apr; 72(4):616-8. PubMed ID: 1690793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells.
    Dietl J; Horny HP; Ruck P; Kaiserling E
    Cancer; 1993 Apr; 71(8):2562-8. PubMed ID: 8453580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.
    Saito T; Tanaka R; Yoshida S; Washiyama K; Kumanishi T
    Surg Neurol; 1988 Jun; 29(6):435-42. PubMed ID: 3259730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical aspects of adoptive immunotherapy with tumor-infiltrating lymphocytes].
    Yahata G; Okada Y; Honda S; Tanaka K; Tokunaga A; Takahashi T; Seidou T; Takeuchi S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1474-82. PubMed ID: 2471459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes.
    Saris SC; Spiess P; Lieberman DM; Lin S; Walbridge S; Oldfield EH
    J Neurosurg; 1992 Mar; 76(3):513-9. PubMed ID: 1738033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
    Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
    No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies.
    Nakanoma T; Nakamura K; Deguchi N; Fujimoto J; Tazaki H; Hata J
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):409-13. PubMed ID: 1455691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lymphoid cells isolated from human gliomas.
    Farmer JP; Antel JP; Freedman M; Cashman NR; Rode H; Villemure JG
    J Neurosurg; 1989 Oct; 71(4):528-33. PubMed ID: 2795172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
    Bodey B; Bodey B; Siegel SE
    Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
    Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
    Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomagnetic separation of infiltrating T lymphocytes from brain tumors.
    Bosnes V; Hirschberg H
    J Neurosurg; 1989 Aug; 71(2):218-23. PubMed ID: 2664096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.